Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: An overview

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 9, 2010, Pages 1118-1125

  Kirkegaard, Ida ^a   Uldbjerg, Niels ^a   Oxvig, Claus ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Biochemistry; Molecular biology; PAPP A; Prenatal diagnosis; Pro MBP

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN; BIOLOGICAL MARKER; MAJOR BASIC PROTEIN;

BIOCHEMISTRY; BIOSYNTHESIS; CHROMOSOME ABERRATION; FEMALE; HUMAN; MALE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; BLOOD; CARDIOVASCULAR DISEASES; FIRST TRIMESTER PREGNANCY; PHYSIOLOGY; PREGNANCY COMPLICATIONS;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHROMOSOME ABERRATIONS; EOSINOPHIL MAJOR BASIC PROTEIN; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; SOMATOMEDINS;

EID: 77956334908     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016349.2010.505639     Document Type: Review

References (40)

1. Lin TM, Galbert SP, Kiefer D, Spellacy WN, Gall S. Characterization of four human pregnancy-associated plasma proteins. Am J Obstet Gynecol. 1974;118:223-236
2. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chori- onic gonadotropin and pregnancy-associated plasma protein- A. Ultrasound Obstet Gynecol. 1999;13:231-237
3. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. BJOG. 2000; 107:1271-1275
4. Spencer K, Ong C, Skentou H, Liao AW, Nicolaides H. Screening for trisomy 13 by fetal nuchal translucency and maternal serum freebeta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn. 2000;20:411-416
5. Tul N, Spencer K, Noble P, Chan C, Nicolaides K. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn. 1999;19:1035-1042
6. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al. First-trimester maternal serum PAPP- A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004;191: 1446-1451
7. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, pre- eclampsia, and stillbirth. J Clin Endocrinol Metab. 2002;87: 1762-1767
8. Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn. 2008;28:7-10.
9. Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH. First-trimester ultrasound and biochemical markers of aneu- ploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol. 2008;31:147-152
10. Spencer K, Cowans NJ, Avgidou K, Molina F, Nicolaides KH. First-trimester biochemical markers of aneu- ploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol. 2008;31:15-19.
11. Bonno M, Oxvig C, Kephart GM, Wagner JM, Kristensen T, Sottrup-Jensen L, et al. Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest. 1994;71:560-566
12. Tornehave D, Chemnitz J, Teisner B, Folkersen J, Westergaard JG. Immunohistochemical demonstration of pregnancy-associated plasma protein A (PAPP-A) in the syn- cytiotrophoblast of the normal placenta at different gestational ages. Placenta. 1984;5:427-431
13. Silahtaroglu AN, Tumer Z, Kristensen T, Sottrup-Jensen L, Tommerup N. Assignment of the human gene for pregnancy- associated plasma protein A (PAPPA) to 9q33.1 by fluorescence in situ hybridization to mitotic and meiotic chromosomes. Cytogenet Cell Genet. 1993;62:214-216
14. Overgaard MT, Haaning J, Boldt HB, Olsen IM, Laursen LS, Christiansen M, et al. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem. 2000;275:31128-31133
15. Overgaard MT, Sorensen ES, Stachowiak D, Boldt HB, Kristensen L, Sottrup-Jensen L, et al. Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein. Disulfide structure and carbohydrate attachment. J Biol Chem. 2003;278:2106-2117
16. Kristensen T, Oxvig C, Sand O, Moller NP, Sottrup-Jensen L. Amino acid sequence of human pregnancy-associated plasma protein-A derived from cloned cDNA. Biochemistry. 1994; 33:1592-1598
17. Overgaard MT, Boldt HB, Laursen LS, Sottrup-Jensen L, Conover CA, Oxvig C. Pregnancy-associated plasma protein- A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J Biol Chem. 2001;276:21849-21853
18. Oxvig C, Sand O, Kristensen T, Gleich GJ, Sottrup-Jensen L. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem. 1993;268:12243-12246
19. Oxvig C, Sand O, Kristensen T, Kristensen L, Sottrup- Jensen L. Isolation and characterization ofcirculating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Biochim Biophys Acta. 1994;1201:415-423
20. Oxvig C, Haaning J, Hojrup P, Sottrup-Jensen L. Location and nature ofcarbohydrate groups in proform ofhuman major basic protein isolated from pregnancy serum. Biochem Mol Biol Int. 1994;33:329-336
21. Popken-Harris P, Checkel J, Loegering D, Madden B, Springett M, Kephart G, et al. Regulation and processing of a precursor form of eosinophil granule major basic protein (ProMBP) in differentiating eosinophils. Blood. 1998;92: 623-631
22. Overgaard MT, Oxvig C, Christiansen M, Lawrence JB, Conover CA, Gleich GJ, et al. Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproduc- tiveand nonreproductive tissues. BiolReprod. 1999;61:1083-1089
23. Glerup S, Boldt HB, Overgaard MT, Sottrup-Jensen L, Giudice LC, Oxvig C. Proteinase inhibition by proform of eosinophil major basic protein (pro-MBP) is a multistep process of intra- and intermolecular disulfide rearrangements. J Biol Chem. 2005;280:9823-9832
24. Glerup S, Kloverpris S, Laursen LS, gnaes-Hansen F, Thiel S, Conover CA, et al. Cell surface detachment of pregnancy-associated plasma protein-A requires the formation of intermolecular proteinase-inhibitor disulfide bonds and glycosaminoglycan covalently bound to the inhibitor. J Biol Chem. 2007;282:1769-1778
25. Oxvig C, Haaning J, Kristensen L, Wagner JM, Rubin I, Stigbrand T, et al. Identification of angiotensinogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasma. J Biol Chem. 1995;270:13645-13651
26. Christiansen M, Jaliashvili I, Overgaard MT, Ensinger C, Obrist P, Oxvig C. Quantification and characterization of pregnancy-associated complexes of angiotensinogen and the proform of eosinophil major basic protein in serum and amniotic fluid. Clin Chem. 2000;46(8 Pt 1):1099-1105
27. Lawrence JB, Bale LK, Haddad TC, Clarkson JT, Conover CA. Characterization and partial purification of the insulin-like growth factor (IGF)-dependent IGF binding protein-4-specific protease from human fibroblast conditioned media. Growth Horm IGF Res. 1999;9:25-34.
28. Laursen LS, Overgaard MT, Soe R, Boldt HB, Sottrup- Jensen L, Giudice LC, et al. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 2001;504:36-40.
29. Laursen LS, Kjaer-Sorensen K, Andersen MH, Oxvig C. Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5. Mol Endocrinol. 2007;21:1246-1257
30. Sun IY, Overgaard MT, Oxvig C, Giudice LC. Pregnancy- associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane. J Clin Endocrinol Metab. 2002;87:5235-5240
31. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995;16:3-34.
32. Clemmons DR. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol. 1998;140:19-24.
33. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Fuchtbauer EM, et al. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development. 2004;131:1187-1194
34. Overgaard MT, Glerup S, Boldt HB, Rodacker V, Olsen IM, Christiansen M, et al. Inhibition of proteolysis by the pro- form of eosinophil major basic protein (proMBP) requires covalent binding to its target proteinase. FEBS Lett. 2004; 560:147-152
35. Gyrup C, Christiansen M, Oxvig C. Quantification of pro- teolytically active pregnancy-associated plasma protein-A with an assay based on quenched fluorescence. Clin Chem. 2007; 53:947-954
36. Christiansen M, Larsen SO, Oxvig C, Qin QP, Wagner JM, Overgaard MT, et al. Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers. Clin Genet. 2004;65:11-16.
37. Smith R, Bischof P, Hughes G, Klopper A. Studies on pregnancy-associated plasma protein A in the third trimester of pregnancy. Br J Obstet Gynaecol. 1979;86:882-887
38. Bischof P, DuBerg S, Herrmann W, Sizonenko PC. Pregnancy-associated plasma protein-A (PAPP-A) and hCG in early pregnancy. Br J Obstet Gynaecol. 1981;88:973-975
39. Bischof P, Amandruz M, Weil-Franck C, Baeriswyl JP, Weil A, Hermann WL, et al. The disappearance rate of pregnancy-associated plasma protein-A (PAPP-A) after the end of normal and abnormal pregnancies. Arch Gynecol. 1984;236:93-98
40. DuBerg S, Bischof P, Schindler AM, Beguin F, Herrmann W, Sizonenko PC. Tissue and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A): comparison with other fetoplacental products. Br J Obstet Gynaecol. 1982;89:352-357